Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice - PubMed (original) (raw)
Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice
Y F Wang et al. Nat Med. 1998 Feb.
Abstract
Intravenous tissue plasminogen activator (tPA) is used to treat acute stroke because of its thrombolytic activity and its ability to restore circulation to the brain. However, this protease also promotes neurodegeneration after intracerebral injection of excitotoxins such as glutamate, and neuronal damage after a cerebral infarct is thought to be mediated by excitotoxins. To investigate the effects of tPA on cerebral viability during ischemia/reperfusion, we occluded the middle cerebral artery in wild-type and tPA-deficient mice with an intravascular filament. This procedure allowed us to examine the role of tPA in ischemia, independent of its effect as a thrombolytic agent. tPA-deficient mice exhibited approximately 50% smaller cerebral infarcts than wild-type mice. Intravenous injection of tPA into tPA-/- or wild-type mice produced larger infarcts, indicating that tPA can increase stroke-induced injury. Since tPA promotes desirable (thrombolytic) as well as undesirable (neurotoxic) outcomes during stroke, future therapies should be aimed at countering the excitotoxic damage of tPA to afford even better neuroprotection after an acute cerebral infarct.
Comment in
- tPA: a neuron buster, too?
del Zoppo GJ. del Zoppo GJ. Nat Med. 1998 Feb;4(2):148-50. doi: 10.1038/nm0298-148. Nat Med. 1998. PMID: 9461181 No abstract available.
Similar articles
- Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL. Liberatore GT, et al. Stroke. 2003 Feb;34(2):537-43. doi: 10.1161/01.str.0000049764.49162.76. Stroke. 2003. PMID: 12574572 - Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
Reddrop C, Moldrich RX, Beart PM, Farso M, Liberatore GT, Howells DW, Petersen KU, Schleuning WD, Medcalf RL. Reddrop C, et al. Stroke. 2005 Jun;36(6):1241-6. doi: 10.1161/01.STR.0000166050.84056.48. Epub 2005 May 5. Stroke. 2005. PMID: 15879331 - Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.
Tabrizi P, Wang L, Seeds N, McComb JG, Yamada S, Griffin JH, Carmeliet P, Weiss MH, Zlokovic BV. Tabrizi P, et al. Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2801-6. doi: 10.1161/01.atv.19.11.2801. Arterioscler Thromb Vasc Biol. 1999. PMID: 10559029 - A novel mouse model of thromboembolic stroke.
Chen Y, Zhu W, Zhang W, Libal N, Murphy SJ, Offner H, Alkayed NJ. Chen Y, et al. J Neurosci Methods. 2015 Dec 30;256:203-11. doi: 10.1016/j.jneumeth.2015.09.013. Epub 2015 Sep 18. J Neurosci Methods. 2015. PMID: 26386284 Free PMC article. Review. - Clinical implications of the involvement of tPA in neuronal cell death.
Tsirka SE. Tsirka SE. J Mol Med (Berl). 1997 May;75(5):341-7. doi: 10.1007/s001090050119. J Mol Med (Berl). 1997. PMID: 9181475 Review.
Cited by
- Neuroserpin and Extracellular Vesicles in Ischemic Stroke: Partners in Neuroprotection?
Brenna S, Glatzel M, Magnus T, Puig B, Galliciotti G. Brenna S, et al. Aging Dis. 2024 Oct 1;15(5):2191-2204. doi: 10.14336/AD.2024.0518. Aging Dis. 2024. PMID: 39191396 Free PMC article. Review. - Novel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in Stroke.
El-Hajjar L, Miranda E, El-Sabban M, Daher J. El-Hajjar L, et al. Rev Cardiovasc Med. 2023 Dec 15;24(12):354. doi: 10.31083/j.rcm2412354. eCollection 2023 Dec. Rev Cardiovasc Med. 2023. PMID: 39077081 Free PMC article. - Efficacy and safety of intravenous tenecteplase compared to alteplase before mechanical thrombectomy in acute ischemic stroke: a meta-analysis.
Wu N, Doeppner TR, Hermann DM, Gronewold J. Wu N, et al. J Neurol. 2024 Jul;271(7):3928-3941. doi: 10.1007/s00415-024-12445-7. Epub 2024 May 23. J Neurol. 2024. PMID: 38782799 Free PMC article. - Biocompatible aggregation-induced emission active polyphosphate-manganese nanosheets with glutamine synthetase-like activity in excitotoxic nerve cells.
Wang J, Zhao X, Tao Y, Wang X, Yan L, Yu K, Hsu Y, Chen Y, Zhao J, Huang Y, Wei W. Wang J, et al. Nat Commun. 2024 Apr 26;15(1):3534. doi: 10.1038/s41467-024-47947-5. Nat Commun. 2024. PMID: 38670989 Free PMC article. - The paradox of tPA in ischemic stroke: tPA knockdown following recanalization improves functional and histological outcomes.
Challa SR, Nalamolu KR, Fornal CA, Baker IM, Mohandass A, Mada SR, Wang BC, Pinson DM, Lahoti S, Klopfenstein JD, Veeravalli KK. Challa SR, et al. Exp Neurol. 2024 Apr;374:114727. doi: 10.1016/j.expneurol.2024.114727. Epub 2024 Feb 14. Exp Neurol. 2024. PMID: 38360257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources